SCHEMBL6790632

SCHEMBL6790632

COc1ccccc1CN1CCC(CS(=O)(=O)c2ccc(Oc3ccccc3)cc2)(C(=O)O)CC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MMP1 P03956 2/20 0.53
MMP2 P08253 1/20 0.53
MMP3 P08254 1/20 0.53
MMP9 P14780 1/20 0.53
MMP13 P45452 1/20 0.53
CYP2D6 P10635 6/20 0.53
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
TSHR P16473 3/20 0.50
USP2 O75604 2/20 0.50
HTT P42858 1/20 0.49
KCNH2 Q12809 1/20 0.48
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6787427 0.79 MMP1 (0.81) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL6789708 0.79 MMP1 (0.81) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6791022 0.75 MMP1 (0.71) MMP1MMP2MMP3MMP9MMP13
SCHEMBL7310714 0.74 MMP1 (0.63) KMT2AMMP1MMP2MMP3MMP9
SCHEMBL6268597 0.72 ADAM17 (0.69) MMP1MMP2MMP9MMP13
SCHEMBL6792766 0.70 MMP1 (0.65) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6785762 0.70 MMP1 (0.73) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL6788984 0.70 MMP1 (0.73) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL21044159 0.70 MEN1 (0.70) MEN1KMT2ACYP2D6ALDH1A1KDM4E
SCHEMBL6789202 0.69 MMP13 (1.00) MMP1MMP2MMP3MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds G.D. SEARLE & CO. 2004-05-20 US disclosed
US-6638952-B1 Matrix metalloprotease inhibitors PHARMACIA CORPORATION 2003-10-28 US disclosed
EP-0983257-A4 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO CO (US) 2001-05-02 EP disclosed
EP-0983257-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS Monsanto Company (US) 2000-03-08 EP disclosed
WO-1998039315-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO COMPANY (US) 1998-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds MMP1, MMP2, MMP10 MEN1 3804/4885KMT2A 1233/4885MMP1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.